Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
As AI disrupts traditional career paths, these college students are skipping corporate internships for San Francisco hacker houses and incubators. Plus: The end of Anthropic’s Fable ban, high-earner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results